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Edited by Robert B. RussellAbstract Similar disease phenotypes are engendered as a result
of the modular nature of gene networks; thus we hypothesized
that all human genetic disease phenotypes appear in similar mod-
ular styles. Network representations of phenotypes make it pos-
sible to explore this hypothesis. We investigated the modularity
of a network of genetic disease phenotypes. We computationally
extracted phenotype modules and found that the modularity is
well correlated with a physiological classiﬁcation of human dis-
eases. We also found correlations between the modularity and
functional genomics as well as its connection to drug-target asso-
ciations.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Evidence from many sources suggests that diseases with
overlapping clinical phenotypes are caused by mutations of
functionally related genes [1]. For example studies have indi-
cated that common processes and pathways are involved in
inherited cerebellar ataxias [2]. Such genotype–phenotype
associations have been used to develop new computational
tools for discovering the candidate genes of diseases. For
example, methods based on Gene Ontology annotations [3],
gene expression data [4] and protein–protein interactions
[5,6] have been developed. A similar method has recently been
used to construct a large-scale human disease network [7] for
analysis of all known phenotypes and disease genes. The use
of networks to represent interactions between genetic disease
phenotypes has proved to be a valuable model for systemati-
cally investigating the functions of genes on a large scale [8].
Functionally related genes generally indicate genes which be-
long to the same functional modules, such as co-expression
modules, protein complexes or cellular pathways. Such func-
tional relationships are consistent with the concept of modu-
larity in biological networks and indicate the existence of
densely connected sub-graphs, which represent the fundamen-
tal functional units of biological systems [9]. We may surmise
that a family of similar disease phenotypes could also appearAbbreviations: OMIM, Online Mendelian Inheritance in Man; FDA,
Food and Drug Administration; MSC, module-speciﬁc coeﬃcient
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doi:10.1016/j.febslet.2008.06.023as modular in a phenotype network, if they were caused by
the dysfunction of a module in a gene network. Using a pheno-
type network constructed by van Driel et al. [10], we conﬁrmed
the existence of modularity and computationally extracted
modules which signiﬁcantly coincide with disease classiﬁca-
tion. We further investigated the relationship between the
modularity and functional genomics as well as its connection
to drug-target associations.2. Materials and methods
2.1. Phenotype network
A phenotype network consisting of disease phenotypes as nodes and
phenotypic similarity as edges was constructed by van Driel et al. [10]
using the Online Mendelian Inheritance in Man (OMIM) database
[11]. Because some OMIM records have since been moved to other re-
cords, we removed them from the network to avoid technical error. We
obtained a network with 4146 phenotypes and 29489 edges using a
similarity of 0.5 as the threshold. However, selection of the threshold
had no signiﬁcant eﬀect on the modularity of the disease network (Sup-
plementary Table S1). In order to link phenotypes in the network to
known disease genes, OMIM genotype–phenotype associations for
1807 genes and 2265 disease phenotypes were downloaded on Novem-
ber 23 2007 from Ensembl [12] using the data mining tool BioMART
[13].
2.2. Physiological classiﬁcation of disease phenotypes
We used the classiﬁcation of disease phenotypes which was manually
established by Goh et al. [7] to evaluate the signiﬁcance of modularity
in the phenotype network. Two thousand nine hundred and twenty-
nine phenotypes were classiﬁed into 22 primary disorder classes based
on the physiological system aﬀected [7]. We did not merge several phe-
notypes into a single disorder as Goh et al. did. We obtained 1184 phe-
notypes within 21 disease classes in our phenotype network.
2.3. Tissue-selective genes
Two lists of tissue-selective genes were downloaded from HugeIndex
[14] and a microarray dataset of healthy human tissues [15]. We
merged them into one dataset by discarding genes that were identiﬁed
as being expressed in diﬀerent tissues in the two datasets. In the end we
obtained 2565 genes which are tissue-selective in 27 tissues.
2.4. Drug-target associations
Drug-target associations were analyzed recently at the network level
[16] using the DrugBank database [17]. We downloaded the dataset
which was used in that paper. The dataset contains 890 US Food
and Drug Administration (FDA)-approved drugs and 808 experimen-
tal drugs with known protein targets. Fifty FDA-approved drugs and
37 experimental drugs that have at least two protein targets are pre-
sented in the OMIM genotype–phenotype associations.
2.5. Measuring the modular structure of phenotype network
Dyadicity (D) and heterophilicity (H) are two network properties of
nodes which were recently proposed [18] for quantifying whether nodes
with similar characteristics have a tendency to link to each other. Weblished by Elsevier B.V. All rights reserved.
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physiological class tend to cluster together in our phenotype network.
If D 1 andH> 1, phenotypes in the speciﬁc disease class must have
a clear clustering tendency within the network. Details of the discus-
sion and computation of D and H are described in the Supplementary
material.
2.6. Module-speciﬁc coeﬃcient
To measure if two or more disease phenotypes of one mutated gene
are conserved in a module, we used a module-speciﬁc coeﬃcient (MSC)
which is deﬁned as
MSCðiÞ ¼
Pn
s¼1
dis
di
 2
 1di
1 1di
where di is the number of the associated phenotypes of mutated gene i,
dis is the number of phenotypes of gene i in module s, and n is the total
number of modules in which the phenotypes of gene i participate. MSC
is close to 0 if the associated phenotypes of a mutated gene are uni-
formly distributed among modules and close to 1 if they tend to be
within a speciﬁc module.3. Results
3.1. The existence of modularity in a human phenotype network
Visualization of the human phenotype network using 21 dis-
ease classes indicated that phenotypes within the same disease
class are clustered into densely connected groups (Fig. 1 and
Supplementary Table S2). Most of the disease classes are dya-Fig. 1. Visualization of the phenotype network using 21 disease classes
was drawn with the network visualization software Pajek (http://
vlado.fmf.uni-lj.si/pub/networks/pajek/). Diﬀerent colors indicate dif-
ferent disease classes and unclassiﬁed phenotypes are not shown.dic (D 1) and heterophobic (H 1), revealing a highly
modular structure (Fig. 2). However, a few disease classes
are heterophilic, suggesting that they tend to have phenotypes
that overlap among diﬀerent categories of diseases. These dis-
eases include developmental, skeletal and ear, nose, throat.
For instance, developmental diseases, in which a delay occurs
in physical or mental development, tend to overlap with other
diseases. This is logical because most developmental disorders
would be expected to aﬀect multiple tissues. An interesting
observation is that although phenotypes in the ear, nose,
throat class have strong heterophilicity with other disease clas-
ses, the dyadicity of this class is very large (180). This sug-
gests that the ear, nose, throat class may be a densely
connected part of the network even though it has many con-
nections to phenotypes in other classes.3.2. Extracting the modules of a human phenotype network
We identiﬁed modules in the phenotype network using the
spectral algorithm, which was developed by Newman [19]
and is based on modularity Q (Details of the algorithm are de-
scribed in the Supplementary material). The maximal modu-
larity Q equals 0.78, which indicates a distinctly modular
structure rather than a random network (Supplementary Fig.
S1). However the method could not identify the hierarchical
structure of the modules. Therefore, we decomposed all mod-
ules which had more than 100 phenotypes into sub-modules. If
the sub-network of phenotypes in a module had a clear, sec-
ondary modular structure (Q P 0.5), we used the sub-mod-
ules instead of the ﬁrst level module. This method allowed us
to identify 231 modules, 214 of which were based on the sec-
ondary level of modularity (Supplementary material).3.3. Modularity is signiﬁcantly correlated with disease
classiﬁcation
We used the disease classiﬁcation dataset to see if the disease
phenotypes within a single module tended to fall within the
same disease class. We used the method described in [20] that
computes a P value for the functional enrichment of modules
in protein–protein interaction networks (Supplementary mate-
rial). The P value proﬁle for the 21 disease classes in each mod-
ule with more than ﬁve phenotypes is plotted in Fig. 3. When
we used 103 or 104 as the cutoﬀ for statistical signiﬁcance for
each class, almost all modules were signiﬁcantly enriched with
one or two (three for a few modules) disease classes.
van Driel et al. [10] constructed a set of phenotype similari-
ties by text-mining all records that describe genetics disorders
in the OMIM database [11] using medical subject headings
(MeSH) [21]. The nature of the similarity measure ensures that
two phenotypes will be connected in the network if they have
similar clinical traits. As expected, phenotypes in a disease
class tend to group in the network. However, they can be di-
vided into many diﬀerent modules. For example, phenotypes
in the neurological disease class are distributed into about
ten modules; of them, one module contains primarily ataxia
phenotypes, such as spinocerebellar ataxia and cerebellar atax-
ia; and one module contains mostly Charcot-Marie-Tooth dis-
ease phenotypes. Thus modules generally are subclasses of the
primary disease classes. In addition, in several cases, some phe-
notypes in diﬀerent disease classes may be grouped together
because they have similar clinical traits. These results indicate
that the network method can not only provide a computa-
Fig. 2. Log–log plot of dyadicity and heterophilicity of 21 disease classes. Most of the disease classes are in the upper-left area
(log10D 0 and log10H  0), revealing a highly modular structure.
Fig. 3. P value proﬁle for 21 disease classes in modules. Each small square in the grid shows the statistical signiﬁcance of the enrichment of a speciﬁc
function in a module. Signiﬁcance levels are indicated by diﬀerent grey scales.
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mined manually by Goh et al. [7], but also provide a more spe-
ciﬁc classiﬁcation of disease phenotypes. Supplementary Fig.
S2 shows a cartographic representation of the phenotype net-
work using disease classiﬁcation.
3.4. Correlations between phenotype modules and gene function
A set of genes is called enriched in a module if their associ-
ated phenotypes are overrepresented in the module. Because
the highly speciﬁc tissue expression of a gene indicates that
the gene performs a tissue-speciﬁc function [7], we analyzed
whether tissue-selective disease genes are enriched in modules
using a method similar to that used to analyze the disease clas-
siﬁcation. The result revealed that tissue-selective genes tend tobe module-speciﬁc. Fig. 4A shows that 11 tissues are enriched
in 21 modules (P < 0.01). A comparison with the disease clas-
siﬁcation in these modules conﬁrms that tissue-selective genes
tend to cause corresponding physiological diseases (Table 1).
Furthermore, using GO annotation we investigated whether
disease genes in a phenotype module tend to have similar gene
functions [22]. GO homogeneity (GH) has previously been
used [7] to investigate if genes associated with a particular dis-
order share similar functional characteristics. We used GH to
measure the functional similarity of genes in a module (Supple-
mentary material). The results indicate that disease genes with-
in modules share signiﬁcantly higher functional similarity than
do random controls (Supplementary Fig S3). Thus phenotype
modules may be used to infer the genetic foundations of phe-
Fig. 4. Relationship between modularity and functional genomics. (A)
The enrichment of tissue-selective genes in modules. (B) The pheno-
types of pleiotropic genes tend to be module-speciﬁc. (C) The target
proteins of FDA-approved drugs tend to associate with module-
speciﬁc phenotypes.
Table 1
Tissue-selective genes and disease classiﬁcations in modules
Tissue Module ID P value
of tissue
Disease
classiﬁcation
P value of
classiﬁcation
Brain 179 0.00058 Neurological <105
Heart 194 0.00123 Cardiovascular <105
199 0.00064 Cardiovascular <105
Kidney 44 0.00001 Renal 0.00051
Liver 64 0.00305 Metabolic 0.00004
161 0.00005 Metabolic <105
162 0.00014 Metabolic <105
165 0.00002 Psychiatric 0.00013
173 0.00026 Metabolic <105
226 0.00097 Gastrointestinal <105
Muscle 161 0.00317 Metabolic <105
195 0.00132 Muscular <105
196 0.00022 Muscular <105
201 0.00084 Muscular <105
Skin 140 0.00002 Dermatological <105
Thymus 214 <105 Immunological <105
Thyroid 17 <105 Endocrine <105
Vulva 140 <105 Dermatological <105
Testis 2 0.00966 Developmental <105
2 0.00966 Skeletal <105
2 0.00966 Multiple <105
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causing the same disorder tend to be co-expressed and func-
tionally similar. Our study extended these conclusions from
genetically heterogeneous single diseases to groups of pheno-
typically similar diseases.
3.5. Correlations between phenotype modules and gene
pleiotropy
Pleiotropy refers to a single gene that inﬂuences multiple
phenotypic traits. Goh et al. [7] have shown that diseasescaused by the same gene tend to be within the same disease
class. Here we similarly investigated whether phenotypes of a
pleiotropic gene tend to group together using the modularity
found in a phenotype network. The phenotype network is
associated with 394 pleiotropic genes whose mutation can lead
to two or more disease phenotypes. Phenotypes of a pleiotro-
pic gene may be distributed widely in the phenotype network;
or the reverse may be true. In order to investigate this issue, we
constructed a set of 394 pseudo-pleiotropic genes as a random
control (Supplementary material). Fig. 4B indicates that the
mean MSC of the pleiotropic genes is signiﬁcant higher than
that of the randomly selected pseudo-pleiotropic genes
(P < 108). This indicates that the diﬀerent phenotypes of a
pleiotropic gene tend to be module-speciﬁc, suggesting that
the pleiotrophy of gene function does not obscure the modular
view of genetic disease [8]. Because phenotypes in modules are
generally engendered by mutations in genes with similar func-
tions, as we showed in Section 3.4, we speculate that the pleio-
tropic eﬀects of a human gene might not be derived from the
multiple functions of the gene. This inference is supported by
a previous study in yeast that showed that pleiotropy of a yeast
gene is not conferred by multiple molecular functions of the
gene, but by multiple consequences of a single molecular func-
tion [23]. However, multi-cellular organisms are more complex
than yeast and the identiﬁcation of pleiotropic genes of hu-
mans is far from complete, so the results from yeast may not
be applicable to our study. Yet another possible explanation
for our result may be study bias. For instance, for any given
gene associated with a phenotype scientists are more likely to
discover that the gene also inﬂuences a related phenotype than
a completely diﬀerent phenotype. Therefore, our ﬁnding needs
further investigation in the future when a more comprehensive
disease genes dataset is available.
3.6. Correlations between phenotype modules and drug-target
association
A similar computation to that used for gene pleiotropy was
also applied to multi-target drugs. Some drugs target at least
X. Jiang et al. / FEBS Letters 582 (2008) 2549–2554 2553two proteins, which are generally associated with diﬀerent phe-
notype s. MSC can measure whether the target proteins of a
single drug are associated with disease phenotypes in a speciﬁc
module. Fig. 4C and Supplementary Table S3 show that the
mean MSC of FDA-approved drugs is signiﬁcantly higher
than that of drugs with randomly selected targets (100000 sim-
ulations, P < 108). A similar result was obtained for experi-
mental drugs (Supplementary Fig. S4, Supplementary Table
S4). We have showed that the phenotype modules correlate
with the functional modules of genes; thus, this result may re-
ﬂect the fact that drugs usually do not only aﬀect the action of
isolated targets, but inﬂuence entire pathways or functional
modules [24].4. Discussion
With the arrival of the post-genomics era, phenotype net-
works have become a powerful tool for studying gene function
and exploring the candidate genes of disease [8,25]. The meth-
od proposed in this paper reveals the modularity of a pheno-
type network by systemically analyzing human genetic
diseases phenotypes. We obtained signiﬁcant results even
though current data sets are far from complete. However, we
cannot ignore the potential caveats of the analysis. First, the
similarity measure used here is not a perfect measure of pheno-
type interactions, and the records in the OMIM are not a stan-
dard library for describing disease phenotypes. Although
previous works have veriﬁed the reliability of the similarity
measure [5,10], further advancements in phenomic techniques
will doubtless provide more precise results. Second, a pheno-
type network is a model to simplify the phenotypic relation-
ships discretely at the phenomics level. Information such as
the strength of a phenotype interaction may be lost in the bin-
ary simpliﬁcation, so it may be valuable to study the modular-
ity using a weighted network analysis in the future.
Although clustering may be another approach for examining
the proposal [3,10], van Driel et al. found that every attempt to
cluster phenotype similarity is intrinsically subjective [10]. In
any case, a systematic validation of the signiﬁcance of disease
and functional classiﬁcation of phenotype modules has not
been carried out. Nevertheless, network representation oﬀers
a rapid visual indication of the relationships between human
phenotypes. As we showed in this paper, the application of
network theory in phenomics can indeed provide us with
new information about the relationship between disease and
disease genes.
Biological networks are modular [9]. This principle is impor-
tant because it helps to account for the robustness and reliabil-
ity of biological systems [26]. The decomposition of a
biological network into modules provides deep insight into liv-
ing systems and human diseases [9]. We believe that the decom-
position of phenotype networks can help us to understand the
relationship between human diseases and their genetic mecha-
nisms. Network comparisons between diﬀerent species can also
be an eﬀective tool for mining conserved modules of pathways
or biological networks [27]. This method may be used to dis-
cover associations between modules in a phenotype network
and a gene network. Future attempts using these aspects will
speed up the integration of the genome, interactome and phe-
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